An error occurred while fetching the data.
Error details: Error: INTERNAL_ERROR for 20771aea-60c3-9ed6-6608-2c36869b029b: {"response":{"errors":[{"message":"INTERNAL_ERROR for 20771aea-60c3-9ed6-6608-2c36869b029b","locations":[{"line":93,"column":7}],"path":["articlePackages"],"extensions":{"classification":"INTERNAL_ERROR"}},{"message":"INTERNAL_ERROR for 20771aea-60c3-9ed6-6608-2c36869b029b","locations":[{"line":115,"column":7}],"path":["youmightlike"],"extensions":{"classification":"INTERNAL_ERROR"}}],"data":{"articleData":{"uri":"/2012/08/03/bms-exec-charged-with-insider-trading/","canonicalUrl":"https://www.treasuryandrisk.com/2012/08/03/bms-exec-charged-with-insider-trading/","generatedId":"hee45kldd","naturalId":"blogAndPostId/blog/post/411-7800","recombeeId":"411-7800","type":"ARTICLE","postFormat":null,"kickerPresentedBy":{"label":"","value":""},"breadcrumb":[],"presentedBy":"","title":"BMS Exec Charged with Insider Trading","readtime":"4","timeToRead":"4 minute","prettyModified":"","prettyDateTime":"August 03, 2012 at 05:48 AM","needToKnow":[],"byline":"David Voreacos and Drew Armstrong, Bloomberg","nofollow":false,"showDisclaimer":true,"authors":[{"name":"David Voreacos","description":"","imageLarge":"","webUrl":"/author/profile/david-voreacos/"},{"name":"Drew Armstrong, Bloomberg","description":"","imageLarge":"https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g","webUrl":"/author/profile/drew-armstrong-bloomberg/"}],"publication":"Treasury and Risk","kicker":"News","kickerNode":[{"name":"News","slug":"news-kicker","uri":"/news/","sectionName":"News"}],"prettyDate":"August 03, 2012","pubDate":"2012-08-03 05:48:00:000","modifiedDate":"","isDownload":"false","primaryCategory":{"channelName":"","sectionName":"","name":"","uri":"","slug":"","channelUri":""},"tags":[],"image":{"uri":"","width":"","height":"","alt":""},"embed1":"","embed2":"","summary":"Assistant treasurer Ramnarine accused of investing in companies targeted for acquisition by the drugmaker.","categories":[{"name":"Corporate Finance","uri":"/corporate-finance/","channelName":"Corporate Finance"},{"name":"Global Markets","uri":"/global-markets/","channelName":"Global Markets"},{"name":"Governance/Regulation & Compliance","uri":"/global-markets/governance-regulation-compliance/","channelName":"Global Markets"},{"name":"Kicker","uri":"//","channelName":"Kicker"},{"name":"News","uri":"/news/","channelName":"Kicker"}],"allCategories":[{"sectionName":"","channelName":"Corporate Finance"},{"sectionName":"","channelName":"Global Markets"},{"sectionName":"Governance/Regulation & Compliance","channelName":"Global Markets"},{"sectionName":"","channelName":"Kicker"},{"sectionName":"News","channelName":"Kicker"}],"bodyArray":["<p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Bristol-Myers Squibb Co. executive Robert Ramnarine was charged with insider trading for making $311,361 in illegal profit by buying stock options in three companies targeted for acquisition.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">The FBI arrested Ramnarine, 45, and he appeared today in federal court in Newark, New Jersey, where he was released on $250,000 bond. Ramnarine's jobs included executive director of pensions and savings investments and assistant treasurer for capital markets.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">He helped the New York-based drugmaker evaluate whether to buy targeted companies, including ZymoGenetics Inc., Pharmasset Inc. and Amylin Pharmaceuticals Inc., the Federal Bureau of Investigation said. As he conducted due diligence on pension and savings plans of those companies, he also bought options in all three, violating his duty not to profit from inside information, according to the FBI.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">From his office in Princeton, New Jersey, Ramnarine also conducted Internet searches to determine whether he could be detected by authorities, according to the Securities and Exchange Commission, which sued him today. One search was on the term “can stock option be traced to purchase inside trading,” according to the civil complaint.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">“Ramnarine tried to educate himself about how the SEC investigates insider trading so he could avoid detection,” Daniel M. Hawke, chief of the SEC's Market Abuse Unit, said in a statement. “Our charges against Ramnarine should serve notice that when you violate insider trading laws, no matter how you scheme, you will be caught.”</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Ramnarine, of East Brunswick, New Jersey, faces three counts of securities fraud, each carrying a maximum prison term of 20 years. The SEC seeks a court order to freeze his brokerage account assets.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">After Ramnarine's court appearance, Peter Carter, his assistant federal public defender, declined to comment.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Bristol-Myers said Ramnarine was placed on administrative leave effective immediately.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\"> </p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\"><strong><!-- pagebreak -->Company Statement</strong></p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Bristol-Myers agreed to buy ZymoGenetics in October 2010 and Amylin in June. It withdrew from talks on buying Pharmasset, which Gilead Sciences Inc. agreed to buy in November 2011 for $11 billion.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Bristol-Myers fell the most in more than 10 years after it announced late yesterday that a patient in a clinical trial for its experimental hepatitis C drug had developed heart failure. The company halted testing of the drug.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Shares fell 8.6 percent to $32.55 at 4 p.m. New York time, after gaining 27 percent in the previous 12 months. It was their worst one-day drop since April 2002.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Bristol-Myers has been acquiring companies and developing drugs to replace top-selling heart drug Plavix, which had $7.09 billion in sales last year. Bristol-Myers agreed to pay $5.3 billion for Amylin, and agreed to pay $885 million for ZymoGenetics.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Bristol-Myers reached a tentative agreement to buy ZymoGenetics on Aug. 12, 2010, triggering three weeks of due diligence, according to the FBI complaint.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Ramnarine bought ZymoGenetics options on Aug. 25 and 26, 2010, and sold on Sept. 8, the day after the deal was announced, for a profit of $30,551, according to the FBI. In an application for one brokerage account used for those trades, Ramnarine falsely stated that he worked at Merck & Co., the FBI said.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Ramnarine was hired in December 1997 and worked from March 2008 to June 2011 as director of pensions and savings investments. He was then promoted to executive director in that office. In July, he was promoted again, to assistant treasurer for capital markets.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">In April, he was responsible for advising Bristol-Myers on how the Amylin transaction would affect the company's capital structure, cash flow and credit rating, according to the FBI. He also spoke with the company's investment bankers at Citigroup Inc. and credit agencies. Ramnarine made $55,784 in illicit profit on the deal, according to the FBI.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">He also made $225,026 in illicit profit on the Pharmasset deal, buying some of his options on his work-issued BlackBerry, according to the arrest complaint.</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">The case is U.S. v. Ramnarine, 12-mj-8121, U.S. District Court, District of New Jersey (Newark).</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\"> </p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Bloomberg News</p> <p xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\"> </p> <p class=\"disclaimer_message\" xmlns:i=\"incisive-repository\" xmlns=\"http://www.w3.org/1999/xhtml\">Copyright 2018 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.</p>"],"slides":[],"video":null},"articlePackages":null,"youmightlike":null,"readnext":{"contents":[{"uri":"/2025/07/10/ntt-closes-record-bond-deal/","title":"NTT Closes Record Bond Deal","byline":"Finbarr Flynn and Caleb Mutua","summary":"The Japanese telecom’s $17.7 billion in dollar and euro bonds marks the biggest-ever offering of foreign bonds by an Asian corporate.","prettyDate":"July 10, 2025","kicker":"News","image":{"uri":"https://k2-prod-alm.s3.us-east-1.amazonaws.com/brightspot/81/51/db0461da4a8199edf0ffadd2fb03/071025-bloomberg-ntt.jpg","width":"1200","height":"800"},"breadcrumb":[],"primaryCategory":{"name":"","uri":"","channelName":"","channelUri":""},"allCategories":[{"channelName":"Corporate Finance","sectionName":"Corporate Borrowing & Debt","slug":"corporate-borrowing-debt","channelUri":"corporate-finance"},{"channelName":"Kicker","sectionName":"News","slug":"news-kicker","channelUri":""}]},{"uri":"/2025/07/10/corporate-optimism-hits-lowest-level-since-2023/","title":"Corporate Optimism Hits Lowest Level Since 2023","byline":"T&R Staff","summary":"Global business leaders expect their operating margins, capex, and long-term borrowing to shrink this quarter.","prettyDate":"July 10, 2025","kicker":"Analysis","image":{"uri":"https://images.treasuryandrisk.com/contrib/content/uploads/sites/411/2024/05/2013-10-22-Global.jpg","width":"1180","height":"889"},"breadcrumb":[],"primaryCategory":{"name":"","uri":"","channelName":"","channelUri":""},"allCategories":[{"channelName":"Kicker","sectionName":"Analysis","slug":"analysis","channelUri":""}]},{"uri":"/2025/07/03/powell-reiterates-fed-would-have-already-cut-rates-this-year-if-not-for-tariffs/","title":"Powell Reiterates Fed Would Have Already Cut Rates This Year, If Not for Tariffs","byline":"Amara Omeokwe","summary":"","prettyDate":"July 03, 2025","kicker":"News","image":{"uri":"https://images.treasuryandrisk.com/contrib/content/uploads/sites/412/2019/07/Powell_Jerome_Glasses_BB_MI800.jpg","width":"800","height":"451"},"breadcrumb":[],"primaryCategory":{"name":"","uri":"","channelName":"","channelUri":""},"allCategories":[{"channelName":"Financial Risk","sectionName":"Interest Rates","slug":"interest-rates","channelUri":"financial-risk"},{"channelName":"Kicker","sectionName":"News","slug":"news-kicker","channelUri":""}]},{"uri":"/2025/07/09/us-immigration-policy-may-hit-economy-hard/","title":"U.S. Immigration Policy May Hit Economy Hard","byline":"Catarina Saraiva","summary":"Newly released Fed study projects that the Trump administration’s approach to immigration and deportation will reduce U.S. GDP growth by nearly 1 percentage point this year.","prettyDate":"July 09, 2025","kicker":"News","image":{"uri":"https://k2-prod-alm.s3.us-east-1.amazonaws.com/brightspot/58/76/5fccfb7d43edb6e1addd1c48fd91/070925-bloomberg-immigrant.jpg","width":"1200","height":"800"},"breadcrumb":[],"primaryCategory":{"name":"","uri":"","channelName":"","channelUri":""},"allCategories":[{"channelName":"Global Markets","sectionName":"Economy","slug":"economy-global-markets","channelUri":"global-markets"},{"channelName":"Kicker","sectionName":"News","slug":"news-kicker","channelUri":""}]},{"uri":"/2025/07/07/junk-loan-market-hits-stumbling-block/","title":"Junk Loan Market Hits Stumbling Block","byline":"Claire Ruckin, Abhinav Ramnarayan and Rachel Graf","summary":"After a pre-summer frenzy in junk loans, the market has started to overheat, prompting investors to get a bit more picky about deals.","prettyDate":"July 07, 2025","kicker":"News","image":{"uri":"","width":"","height":""},"breadcrumb":[],"primaryCategory":{"name":"","uri":"","channelName":"","channelUri":""},"allCategories":[{"channelName":"Kicker","sectionName":"News","slug":"news-kicker","channelUri":""}]}]}},"extensions":{"DateTime":"2025-07-13T01:47:12.400504398","ResponseTime":"?","AuthorizedUser":false,"AlmContext":"AlmContext{clientIP='10.0.253.253', internalIP='true', origin='', authorizedUser='false', Chinchilla, userAccount='null', UCID=null, ipAccount='null', olyEncId='null'}","NavServiceResponse":{"message":"No Content","action":"show-404","data":"","placResultsPublic":null},"DebuggingData":null,"UsedCache":"true","DataUrl":"http://ml2.alm.com:9216/bff-services/content/get-you-may-like-for-content.xqy?naturalId=/2012/08/03/bms-exec-charged-with-insider-trading/&site=www.treasuryandrisk.com&total="},"status":200,"headers":{}},"request":{"query":"\n####\n####\n# QUERY\n# ROUTE:/2012/08/03/bms-exec-charged-with-insider-trading/\n####\n\n\nquery TreasuryandRisk__view_article_no_sitedir{articleData:\n getContent(naturalId: \"/2012/08/03/bms-exec-charged-with-insider-trading/\", site:\"treasuryandrisk.com\") {\n uri\n canonicalUrl\n generatedId\n naturalId\n recombeeId\n type\n postFormat\n kickerPresentedBy {\n \t\t label\n \t\t value\n \t\t}\n breadcrumb{\n name\n \t\turi\n }\n presentedBy\n title\n readtime\n timeToRead\n prettyModified\n prettyDateTime\n needToKnow\n byline\n nofollow\n showDisclaimer\n authors {\n name\n description\n imageLarge\n webUrl\n }\n publication\n kicker\n kickerNode {\n name\n slug\n uri\n sectionName\n }\n prettyDate\n prettyDateTime\n pubDate\n modifiedDate\n isDownload\n primaryCategory {\n channelName\n sectionName\n name\n uri\n slug\n channelUri\n }\n tags\n image {\n uri\n width\n height\n alt\n }\n embed1\n embed2\n summary\n categories {\n name\n uri\n channelName\n }\n allCategories {\n sectionName\n channelName\n } \n bodyArray\n slides {\n title\n image\n caption\n height\n width\n }\n video\n\n }\n articlePackages:\n getPackagesForArticle(docId: \"/2012/08/03/bms-exec-charged-with-insider-trading/\", limit: 3, publication:\"treasuryandrisk.com\") {\n title \n slug\n type \n summary\n cssFile\n navigations {\n name\n link\n }\n articles {\n title\n kicker\n uri\n image {\n uri\n }\n }\n\n \n }\n youmightlike:\n getYouMayLikeForContent(naturalId: \"/2012/08/03/bms-exec-charged-with-insider-trading/\", site:\"treasuryandrisk.com\") {\n uri\n title\n byline\n prettyDate\n readtime\n image {\n uri\n width\n height\n }\n summary\n }\n readnext:\n getStatsList(site:\"treasuryandrisk.com\", topic: \"\", limit: 5, timeframe: \"3days\" ) {\n contents {\n uri\n title\n byline\n summary\n prettyDate\n kicker\n image {\n uri\n width\n height\n }\n breadcrumb{\n name\n \t\turi\n }\n primaryCategory {\n name\n uri\n channelName\n channelUri\n }\n allCategories{\n channelName\n sectionName\n slug\n channelUri\n }\n breadcrumb {\n name\n uri\n }\n }\n\n }\n }"}}